Global Antidiabetic Sglt-2 Inhibitor Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 01-Dec-2022
No. of pages: 98

The report focuses on the Antidiabetic Sglt-2 Inhibitor market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Antidiabetic Sglt-2 Inhibitor market.

Major Players in the Antidiabetic Sglt-2 Inhibitor market are:

Pfizer

Johnson & Johnson

Eli Lilly

Sanofi

Border Valley

GlaxoSmithKline

Bristol-Myers Squibb

Takeda Pharmaceuticals

AstraZeneca

Novo Nordisk

Boehringer Ingelheim

Merck & Co.

Anderson Hay & Grain Inc.

On the basis of types, the Antidiabetic Sglt-2 Inhibitor market is primarily split into:

Canagliflozin

Empagliflozin

Dapagliflozin

On the basis of applications, the market covers:

Hospital

Clinic

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Antidiabetic Sglt-2 Inhibitor Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Antidiabetic Sglt-2 Inhibitor Market Overview
1.1 Product Overview and Scope of Antidiabetic Sglt-2 Inhibitor Market
1.2 Antidiabetic Sglt-2 Inhibitor Market Segment by Type
1.2.1 Global Antidiabetic Sglt-2 Inhibitor Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Antidiabetic Sglt-2 Inhibitor Market Segment by Application
1.3.1 Antidiabetic Sglt-2 Inhibitor Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Antidiabetic Sglt-2 Inhibitor Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Antidiabetic Sglt-2 Inhibitor (2017-2029)
1.5.1 Global Antidiabetic Sglt-2 Inhibitor Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Antidiabetic Sglt-2 Inhibitor Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Antidiabetic Sglt-2 Inhibitor Industry
1.7 Impact of Carbon Neutrality on the Antidiabetic Sglt-2 Inhibitor Industry

2 Antidiabetic Sglt-2 Inhibitor Market Upstream and Downstream Analysis
2.1 Antidiabetic Sglt-2 Inhibitor Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Antidiabetic Sglt-2 Inhibitor Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Pfizer
3.1.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Johnson & Johnson
3.2.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Eli Lilly
3.3.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Sanofi
3.4.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Border Valley
3.5.1 Border Valley Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.5.4 Business Overview
3.6 GlaxoSmithKline
3.6.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Bristol-Myers Squibb
3.7.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Takeda Pharmaceuticals
3.8.1 Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.8.4 Business Overview
3.9 AstraZeneca
3.9.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Novo Nordisk
3.10.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Boehringer Ingelheim
3.11.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Merck & Co.
3.12.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Anderson Hay & Grain Inc.
3.13.1 Anderson Hay & Grain Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Antidiabetic Sglt-2 Inhibitor Market Performance (2017-2022)
3.13.4 Business Overview

4 Global Antidiabetic Sglt-2 Inhibitor Market Landscape by Player
4.1 Global Antidiabetic Sglt-2 Inhibitor Sales and Share by Player (2017-2022)
4.2 Global Antidiabetic Sglt-2 Inhibitor Revenue and Market Share by Player (2017-2022)
4.3 Global Antidiabetic Sglt-2 Inhibitor Average Price by Player (2017-2022)
4.4 Global Antidiabetic Sglt-2 Inhibitor Gross Margin by Player (2017-2022)
4.5 Antidiabetic Sglt-2 Inhibitor Market Competitive Situation and Trends
4.5.1 Antidiabetic Sglt-2 Inhibitor Market Concentration Rate
4.5.2 Antidiabetic Sglt-2 Inhibitor Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price Trend by Type
5.1 Global Antidiabetic Sglt-2 Inhibitor Sales and Market Share by Type (2017-2022)
5.2 Global Antidiabetic Sglt-2 Inhibitor Revenue and Market Share by Type (2017-2022)
5.3 Global Antidiabetic Sglt-2 Inhibitor Price by Type (2017-2022)
5.4 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue and Growth Rate of Canagliflozin (2017-2022)
5.4.2 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue and Growth Rate of Empagliflozin (2017-2022)
5.4.3 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue and Growth Rate of Dapagliflozin (2017-2022)

6 Global Antidiabetic Sglt-2 Inhibitor Market Analysis by Application
6.1 Global Antidiabetic Sglt-2 Inhibitor Consumption and Market Share by Application (2017-2022)
6.2 Global Antidiabetic Sglt-2 Inhibitor Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Antidiabetic Sglt-2 Inhibitor Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Antidiabetic Sglt-2 Inhibitor Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Antidiabetic Sglt-2 Inhibitor Consumption and Growth Rate of Clinic (2017-2022)

7 Global Antidiabetic Sglt-2 Inhibitor Sales and Revenue Region Wise (2017-2022)
7.1 Global Antidiabetic Sglt-2 Inhibitor Sales and Market Share, Region Wise (2017-2022)
7.2 Global Antidiabetic Sglt-2 Inhibitor Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Antidiabetic Sglt-2 Inhibitor Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Antidiabetic Sglt-2 Inhibitor Market Forecast (2022-2029)
8.1 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue Forecast (2022-2029)
8.1.1 Global Antidiabetic Sglt-2 Inhibitor Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Antidiabetic Sglt-2 Inhibitor Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Antidiabetic Sglt-2 Inhibitor Price and Trend Forecast (2022-2029)
8.2 Global Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.3 China Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.5 India Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Antidiabetic Sglt-2 Inhibitor Sales and Revenue Forecast (2022-2029)
8.3 Global Antidiabetic Sglt-2 Inhibitor Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Antidiabetic Sglt-2 Inhibitor Revenue and Growth Rate of Canagliflozin (2022-2029)
8.3.2 Global Antidiabetic Sglt-2 Inhibitor Revenue and Growth Rate of Empagliflozin (2022-2029)
8.3.3 Global Antidiabetic Sglt-2 Inhibitor Revenue and Growth Rate of Dapagliflozin (2022-2029)
8.4 Global Antidiabetic Sglt-2 Inhibitor Consumption Forecast by Application (2022-2029)
8.4.1 Global Antidiabetic Sglt-2 Inhibitor Consumption Value and Growth Rate of Hospital (2022-2029)
8.4.2 Global Antidiabetic Sglt-2 Inhibitor Consumption Value and Growth Rate of Clinic (2022-2029)
8.5 Antidiabetic Sglt-2 Inhibitor Market Forecast Under COVID-19

9 Industry Outlook
9.1 Antidiabetic Sglt-2 Inhibitor Market Drivers Analysis
9.2 Antidiabetic Sglt-2 Inhibitor Market Restraints and Challenges
9.3 Antidiabetic Sglt-2 Inhibitor Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Antidiabetic Sglt-2 Inhibitor Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Antidiabetic Sglt-2 Inhibitor Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Antidiabetic Sglt-2 Inhibitor Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs